Cell models for Down syndrome-Alzheimer's disease research

Area of Science:

• Genetics
• Neuroscience
• Stem Cell Biology

Background:

• Down syndrome (DS), caused by trisomy 21, increases Alzheimer's disease (AD) risk.
• Amyloid precursor protein (APP) gene on chromosome 21 is implicated in DS-AD pathogenesis.
• Current understanding of DS-AD mechanisms is limited.

Purpose of the Study:

• To review the limitations of existing mouse models for Down syndrome and Alzheimer's disease (DS-AD).
• To explore the utility of human induced pluripotent stem cells (iPSCs) in modeling DS-AD.
• To discuss potential applications of iPSC-based models in preclinical DS-AD research.

Main Methods:

• Review of existing literature on DS-AD mouse models.
• Discussion of human iPSC technology for disease modeling.
• Exploration of iPSC-mouse chimera applications.

Main Results:

• Mouse models have limitations in fully recapitulating human DS-AD.
• Human iPSCs provide a more accurate platform for studying DS-AD cellular and molecular pathologies.
• iPSC-derived models and iPSC-mouse chimeras show promise for DS-AD research.

Conclusions:

• Human iPSC technology offers significant advantages over traditional mouse models for studying Down syndrome and Alzheimer's disease.
• iPSC-based approaches are crucial for advancing preclinical studies and understanding DS-AD mechanisms.